Semaglutide 15mg

Description

Semaglutide (GLP-1 Receptor Agonist)

Semaglutide is a synthetic, long-acting analogue of naturally occurring human glucagon-like peptide-1 (GLP-1). In molecular biology, it is specifically engineered with a structural modification—a substitution of structurally hindering amino acids and the attachment of a C18 fatty diacid via a spacer. This design is utilized to study enhanced stability and extended albumin-binding affinity in laboratory settings.

In-Vitro Metabolic & Endocrine Assays

This high-yield 15mg formulation serves as a premium analytical standard for investigating the incretin system and GLP-1 receptor activation. Laboratory protocols frequently deploy Semaglutide in isolated pancreatic beta-cell cultures to observe cAMP-mediated signaling cascades, insulinotropic cellular responses, and receptor down-regulation independent of systemic physiological variables.

Important Research Notice: This compound is manufactured strictly for in-vitro testing and academic laboratory research. For inquiries regarding specific receptor binding assays, solubility profiles, or bulk analytical supplies, please contact our laboratory team.